Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance.
about
Sentinel Lymph Node Biopsy in Patients with Breast Cancer: Comparison of Peritumoral and Periareolar Injection.Comparison of immunohistochemistry with conventional histopathology for evaluation of sentinel lymph node in breast cancer.Tumor characteristics influencing non-sentinel lymph node involvement in clinically node negative patients with breast cancer.Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits.Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapyContraindications of sentinel lymph node biopsy: are there any really?Current management of the axilla in patients with clinically node-negative breast cancer: a nationwide survey of United Kingdom breast surgeonsPrediction of non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastases: evaluation of the tenon scoreBreast Cancer: State of the Art and New Findings.Extent of primary breast cancer surgery: standards and individualized conceptsManual Lymphatic Drainage after Subepidermal Tracer Injection Optimizes Results of Sentinel Lymph Node Labeling in Primary Breast Cancer.Sentinel node biopsy in larger or multifocal breast cancers: to do or not to do.Lymphatic mapping and sentinel lymph node biopsy for breast cancer patients.Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trialEvolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial.Comparison of sonography with sonographically guided fine-needle aspiration biopsy and core-needle biopsy for initial axillary staging of breast cancer.
P2860
Q34210226-1FEE1233-77B3-44DF-9797-E4DD2D509A3BQ34796854-72A41294-E251-46BD-B7BC-0CF14DF7010FQ35142187-3B0CAF53-7C03-4994-BACE-6A57BD756896Q35157554-B06C811F-820A-4812-B680-1F6A3B9DFA91Q35194725-14BA52D0-62ED-43A1-B732-F69B2930E9EBQ35634145-77CE5F87-86A4-40CF-BA16-E1E84CF003BDQ35652997-0D1F2696-4144-4B5A-BDBA-7F2B92D6D653Q35739425-EC1682B1-988A-43A7-AF27-5C9574776B7FQ36295112-42F93D99-AEFF-48B5-A9E1-07B59B813926Q36457859-08296F2C-CA97-47B2-B6FD-6A8468EE93CFQ36744962-60289234-8903-4FC7-BFC9-3B6D5F14E90DQ37082866-F10983FF-F0A6-453C-A1CE-0CB07D0227A7Q37478779-3E627070-CFAF-4A0E-9051-20820EA47F75Q37604182-650F8E8F-A01D-453B-9F1D-C9F36A96CECBQ38049472-341F4F35-8604-4D09-A748-2468EE6DB135Q38444205-319C39E1-FFD2-4BD9-9217-8C3A2D83780C
P2860
Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Axillary recurrence after a ne ...... nce and clinical significance.
@ast
Axillary recurrence after a ne ...... nce and clinical significance.
@en
type
label
Axillary recurrence after a ne ...... nce and clinical significance.
@ast
Axillary recurrence after a ne ...... nce and clinical significance.
@en
prefLabel
Axillary recurrence after a ne ...... nce and clinical significance.
@ast
Axillary recurrence after a ne ...... nce and clinical significance.
@en
P2093
P1476
Axillary recurrence after a ne ...... nce and clinical significance.
@en
P2093
Caroline M M Janssen
Deborah M Kuster
Erik D M Bruggink
Luc J A Strobbe
Marjolein L Smidt
P2888
P356
10.1007/S10434-004-1166-0
P577
2005-01-01T00:00:00Z
P6179
1045171705